0.682
price down icon10.26%   -0.078
after-market Dopo l'orario di chiusura: .70 0.018 +2.64%
loading

Barinthus Biotherapeutics Plc Adr Azioni (BRNS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31
Durata del periodo 3 mesi
Revenues
Operating Expenses
Interest Income/Expense
Benefits Costs and Expenses
Costs And Expenses
Other Operating Income/Expenses
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income Tax Expense/Benefit, Deferred
Income Tax Expense/Benefit
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):